Bicycle Therapeutics plc
BCYC
$4.72
$0.020.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.15M | -59.10M | -78.95M | -60.75M | -51.85M |
| Total Depreciation and Amortization | 1.34M | 1.76M | 1.70M | 1.63M | 1.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.50M | 8.73M | 9.10M | 8.29M | 4.82M |
| Change in Net Operating Assets | -13.02M | -22.55M | -4.63M | -35.54M | 35.93M |
| Cash from Operations | -19.35M | -71.17M | -72.79M | -86.37M | -9.40M |
| Capital Expenditure | -574.00K | -674.00K | -498.00K | -604.00K | -368.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -574.00K | -674.00K | -498.00K | -604.00K | -368.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -48.00K | -31.00K | -46.00K | -43.00K | -42.00K |
| Issuance of Common Stock | 33.00K | 1.00K | 1.00K | 2.00K | 245.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -15.00K | -30.00K | -45.00K | -41.00K | 203.00K |
| Foreign Exchange rate Adjustments | -222.00K | -1.25M | 1.81M | 468.00K | -1.78M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.16M | -73.13M | -71.52M | -86.55M | -11.34M |